The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CURLF | -4.98% | -69.52% | -21.15% | -56% |
| S&P | +18.13% | +110.72% | +16.08% | +157% |
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.
One marijuana industry insider says Monday's Truth Social video is a "trial balloon" testing support for marijuana legalization.
Marijuana legalization may be coming, but does this make Curaleaf stock an automatic buy?
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $314.52M | -8.1% |
| Gross Profit | $116.98M | -5.6% |
| Gross Margin | 37.19% | 1.0% |
| Market Cap | $638.60M | -77.6% |
| Net Income | -$50.60M | -4.2% |
| EBITDA | $58.55M | -8.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $102.27M | 14.4% |
| Accounts Receivable | $67.89M | 5.3% |
| Inventory | 226.5 | -0.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $970.95M | 4.4% |
| Short Term Debt | $85.28M | -37.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -7.74% | -0.8% |
| Return On Invested Capital | -9.37% | -0.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$8.05M | -285.1% |
| Operating Free Cash Flow | $7.57M | -73.8% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.29 | 1.21 | 0.79 | 0.78 | -71.92% |
| Price to Sales | 1.67 | 0.87 | 0.52 | 0.50 | -76.26% |
| Price to Tangible Book Value | -2.90 | -1.45 | -0.80 | -0.72 | -80.65% |
| Price to Free Cash Flow TTM | 63.28 | 17.15 | 11.25 | 13.08 | -76.01% |
| Enterprise Value to EBITDA | 50.19 | 32.36 | 28.86 | 28.29 | -54.12% |
| Free Cash Flow Yield | 1.6% | 5.8% | 8.9% | 7.6% | 316.84% |
| Return on Equity | -18.9% | -23.3% | -25.1% | -24.9% | 22.49% |
| Total Debt | $1.06B | $1.06B | $1.06B | $1.06B | -0.99% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
